"Export bans are more of a problem"… EU skeptical over vaccine IP rights

Unlike the United States, European Union member states are skeptical about the COVID-19 vaccine's intellectual property protection exemption.

EU leaders said the biggest problem in the supply of the COVID-19 vaccine is not intellectual property rights, but export regulation and production capacity.

President Macron entered the conference hall to attend the unofficial summit of EU member states held in Porto, Portugal on the 7th, and said that export restrictions in the United States and the United Kingdom are a bigger problem. Said.

At the meeting, EU leaders discuss proposals from the United States and others to waive intellectual property protection in order to expand production of the COVID-19 vaccine.